Cited by

• Activated T cells in Graves' disease before treatment.

  Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D. Kennedy R, et al. Clin Exp Immunol. 1985 Feb;59(2):377-82. Clin Exp Immunol. 1985. PMID: 3156702 Free PMC article.
• Involvement of the interleukin 2 pathway in the rearrangement and expression of both alpha/beta and gamma/delta T cell receptor genes in human T cell precursors.

  Toribio ML, de la Hera A, Borst J, Marcos MA, Márquez C, Alonso JM, Bárcena A, Martínez C. Toribio ML, et al. J Exp Med. 1988 Dec 1;168(6):2231-49. doi: 10.1084/jem.168.6.2231. J Exp Med. 1988. PMID: 2848921 Free PMC article.
• Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. "Modulation" of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes.

  Bernard A, Gelin C, Raynal B, Pham D, Gosse C, Boumsell L. Bernard A, et al. J Exp Med. 1982 May 1;155(5):1317-33. doi: 10.1084/jem.155.5.1317. J Exp Med. 1982. PMID: 6175720 Free PMC article.
• Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

  Papetti M, Herman IM. Papetti M, et al. Am J Pathol. 2001 Jul;159(1):165-78. doi: 10.1016/s0002-9440(10)61683-5. Am J Pathol. 2001. PMID: 11438464 Free PMC article.
• Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage.

  Hagemeyer CE, Ahrens I, Bassler N, Dschachutaschwili N, Chen YC, Eisenhardt SU, Bode C, Peter K. Hagemeyer CE, et al. J Cell Mol Med. 2010 Jan;14(1-2):290-302. doi: 10.1111/j.1582-4934.2008.00409.x. J Cell Mol Med. 2010. PMID: 20414973 Free PMC article.